179 related articles for article (PubMed ID: 38127240)
1. Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
Le Blanc J; Projean D; Savignac S; Léveillé S; Ducas MP; Brisebois-Boyer A; Marsot A
Clin Pharmacokinet; 2024 Feb; 63(2):183-196. PubMed ID: 38127240
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant
Song X; Han M
Front Cell Infect Microbiol; 2022; 12():874401. PubMed ID: 35873144
[TBL] [Abstract][Full Text] [Related]
3. Using population pharmacokinetics to optimize initial vancomycin dosing guidelines for neonates to treat sepsis caused by coagulase-negative staphylococcus.
Chung E; Seto W
Pharmacotherapy; 2023 Dec; 43(12):1262-1276. PubMed ID: 37574774
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis.
Yellepeddi VK; Lindley B; Radetich E; Kumar S; Bhakta Z; Leclair L; Parrot M; Young DC
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0099223. PubMed ID: 38059634
[TBL] [Abstract][Full Text] [Related]
5. Prospective Cohort Study of Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Adults on Extracorporeal Membrane Oxygenation.
Jung Y; Lee DH; Kim HS
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257444
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation.
Revilla N; Martín-Suárez A; Pérez MP; González FM; Fernández de Gatta Mdel M
Br J Clin Pharmacol; 2010 Aug; 70(2):201-12. PubMed ID: 20653673
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance.
Belabbas T; Yamada T; Egashira N; Hirota T; Suetsugu K; Mori Y; Kato K; Akashi K; Ieiri I
J Infect Chemother; 2023 Apr; 29(4):391-400. PubMed ID: 36682608
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study.
Nolan J; McCarthy K; Farkas A; Avent ML
Int J Clin Pharm; 2023 Dec; 45(6):1444-1451. PubMed ID: 37532840
[TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation.
Okada A; Kariya M; Irie K; Okada Y; Hiramoto N; Hashimoto H; Kajioka R; Maruyama C; Kasai H; Hamori M; Nishimura A; Shibata N; Fukushima K; Sugioka N
J Clin Pharmacol; 2018 Sep; 58(9):1140-1149. PubMed ID: 29762865
[TBL] [Abstract][Full Text] [Related]
10. Assessment of an online calculator's vancomycin dosing and exposure appropriateness in persons who inject drugs with methicillin-resistant Staphylococcus aureus bloodstream infections.
Opitz BJ; Housman ST; Housman EL; Lorenzo MP
J Clin Pharm Ther; 2022 Jun; 47(6):752-758. PubMed ID: 34981545
[TBL] [Abstract][Full Text] [Related]
11. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
[TBL] [Abstract][Full Text] [Related]
13. Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.
Heus A; Uster DW; Grootaert V; Vermeulen N; Somers A; In't Veld DH; Wicha SG; De Cock PA
Int J Antimicrob Agents; 2022 May; 59(5):106579. PubMed ID: 35341931
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review.
Chung E; Sen J; Patel P; Seto W
Clin Pharmacokinet; 2021 Aug; 60(8):985-1001. PubMed ID: 34002357
[TBL] [Abstract][Full Text] [Related]
16. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
Rao Z; Guo SM; Wei YM
Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis.
Fernández de Gatta Mdel M; Santos Buelga D; Sánchez Navarro A; Dominguez-Gil A; García MJ
Clin Pharmacokinet; 2009; 48(4):273-80. PubMed ID: 19492872
[TBL] [Abstract][Full Text] [Related]
18. First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.
Flannery AH; Delozier NL; Effoe SA; Wallace KL; Cook AM; Burgess DS
Pharmacotherapy; 2020 Dec; 40(12):1210-1218. PubMed ID: 33176005
[TBL] [Abstract][Full Text] [Related]
19. An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.
Stockmann C; Olson J; Rashid J; Lubsch L; Young DC; Hersh AL; Frymoyer A; Ampofo K; Liu X; Wang Y; Sherwin CMT; Zobell JT
J Clin Pharmacol; 2019 Feb; 59(2):198-205. PubMed ID: 30371946
[TBL] [Abstract][Full Text] [Related]
20. Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach.
Liu Q; Huang H; Xu B; Li D; Liu M; Shaik IH; Wu X
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
